These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 1961015)
21. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia. Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649 [TBL] [Abstract][Full Text] [Related]
22. Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease. Tien HF; Wang CH; Chen YC; Shen MC; Wu HS; Lee FY; Chuang SM; Liu CH Br J Haematol; 1990 Aug; 75(4):469-75. PubMed ID: 2206998 [TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia. Giere IA; Larripa IB Leuk Lymphoma; 1996 Aug; 22(5-6):519-22. PubMed ID: 8882967 [TBL] [Abstract][Full Text] [Related]
25. Further evidence for the molecular heterogeneity of chronic myeloid leukemia. Hernandez A; Corral L; Muñiz A; Alaez C; Espinosa E; Martinez G; Hernandez P Ann Hematol; 1991 Jun; 62(6):217-20. PubMed ID: 1854884 [TBL] [Abstract][Full Text] [Related]
26. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Johansson B; Fioretos T; Mitelman F Acta Haematol; 2002; 107(2):76-94. PubMed ID: 11919388 [TBL] [Abstract][Full Text] [Related]
27. Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan. Tien HF; Chuang SM; Wang CH; Lee FY; Chien SH; Chen YC; Shen MC; Liu CH Cancer Genet Cytogenet; 1989 May; 39(1):89-97. PubMed ID: 2731152 [TBL] [Abstract][Full Text] [Related]
28. Basophilic crisis of chronic myelogenous leukemia. Ozaki M; Kanemitsu N; Yasukawa M; Fujita S Jpn J Med; 1989; 28(1):67-71. PubMed ID: 2724649 [TBL] [Abstract][Full Text] [Related]
30. A case of chronic myelogenous leukemia with T lymphoblastic and megakaryoblastic mixed crisis. Iwamasa K; Yasukawa M; Fujita S Jpn J Med; 1989; 28(1):89-95. PubMed ID: 2542679 [TBL] [Abstract][Full Text] [Related]
31. Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies. Saglio G; Guerrasio A; Tassinari A; Ponzetto C; Zaccaria A; Testoni P; Celso B; Rege Cambrin G; Serra A; Pegoraro L Blood; 1988 Oct; 72(4):1203-8. PubMed ID: 3167203 [TBL] [Abstract][Full Text] [Related]
32. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient. Kokate P; Dalvi R; Mandava S J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646 [TBL] [Abstract][Full Text] [Related]
33. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia]. Okabe M Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066 [TBL] [Abstract][Full Text] [Related]
34. Simultaneous presence of major secondary chromosomal abnormalities in blast crisis of chronic myeloid leukemia. Lu CM; Wang E; Lawrence HJ Cancer Genet Cytogenet; 2007 Jan; 172(2):174-5. PubMed ID: 17213030 [No Abstract] [Full Text] [Related]
35. [Chromosome aberrations in chronic myeloid leukemia]. Haus O Acta Haematol Pol; 1992; 23(2 Suppl 1):5-12. PubMed ID: 1488873 [TBL] [Abstract][Full Text] [Related]
36. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia. Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030 [TBL] [Abstract][Full Text] [Related]
37. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia. Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202 [TBL] [Abstract][Full Text] [Related]
38. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597 [TBL] [Abstract][Full Text] [Related]
39. Coexistence of translocation(1,19) and the Philadelphia chromosome in a child's first presentation of chronic myeloid leukemia in blast crisis treated with dasatinib. Eckardt MA; Chang VY; Rao NP; Federman N Pediatr Hematol Oncol; 2011 Nov; 28(8):669-75. PubMed ID: 22023462 [TBL] [Abstract][Full Text] [Related]
40. The relationship between the location of the breakpoint within the M-bcr and clinical parameters. Mills KI Leuk Lymphoma; 1993; 11 Suppl 1():73-9. PubMed ID: 8251922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]